| Parameter | Method | Sample Type | Significance | |
|---|---|---|---|---|
|
1 |
HBV Qualitative |
PCR In- house |
Serum |
Efficacy of anti-viral treatment |
|
2 |
HBV Quantitative |
Real Time PCR |
Serum |
Confirmation of HBV in patients |
|
3 |
HBV Genotyping |
PCR In- house |
Serum |
Treatment strategy planning |
|
4 |
HCV Qualitative |
PCR In- house |
Serum |
Efficacy of anti-viral treatment |
|
4 |
HCV Quantitative |
Real Time PCR |
Serum |
Confirmation of HCV in patients |
|
5 |
HCV Genotyping |
PCR In- house |
Serum |
Treatment strategy planning |
|
6 |
HHV-6 Qualitative |
PCR In- house |
Blood |
Confirmation of acute febrile respiratory disease, encephalopathy, hepatitis infection caused by HHV7 virus |
|
7 |
HHV-7 Qualitative |
PCR In- house |
Blood |
Confirmation of acute febrile respiratory disease, encephalopathy, hepatitis infection caused by HHV7 virus |
|
8 |
HHV-8 Qualitative |
PCR In- house |
Blood |
Confirmation of acute febrile respiratory disease, encephalopathy, hepatitis infection caused by HHV7 virus |
|
9 |
HEV Qualitative |
PCR In- house |
Serum |
Confirmation of viral hepatitis (liver inflammation) caused by infection by hepatitis E virus |
|
10 |
Noro virus Qualitative |
PCR In- house |
Stool |
Confirmation of viral gastroenteritis |
|
11 |
HDV Qualitative |
PCR In- house |
Serum |
Efficacy of anti-viral treatment |
|
12 |
HAV Qualitative |
PCR In- house |
Serum |
Confirmation of HAV in patients |
|
13 |
Brucella Qualitative |
PCR In- house |
Blood, Urine, CSF, Ascitic or Pleural fluid |
Confirmation of brucellosis |
